We offer in-office SPRAVATO® (esketamine) treatment for adults with treatment-resistant depression and for major depressive disorder with acute suicidal ideation or behavior. This FDA-approved therapy is administered in a REMS-certified setting under medical supervision.
- For adults who have not responded to traditional antidepressant therapy
- May be appropriate for individuals experiencing severe depressive symptoms, including suicidal thoughts, as clinically indicated
- Administered onsite with required post-dose monitoring
- Insurance coverage available for eligible patients
- Initial psychiatric evaluation required